Intrinsic Value
Inhibikase Therapeutics, Inc. (IKT)
$2.16
-0.14 (-6.09%)
Enterprise Value | -2,423.60 |
---|---|
Net Debt | -8.92 |
Equity Value | -2,414.67 |
Shares Outstanding | 5.33 |
Equity Value Per Share | -452.77 |
Because investors are more interested in the value of the company’s shares alone, we’ll deduct net debt from this value to arrive at a fair value of the company’s equity. Fair Value = Enterprise Value – Debt